Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Fosamprenavir 50mg/ml oral suspension |
| BNF code | 0503010M0AAABAB |
| Virtual Therapeutic Moiety | Fosamprenavir |
| Date identifier became valid | 9 May 2023 |
| Previous product identifier | 416206000 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 1 Jul 2021 |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Fosamprenavir calcium |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 407017006 |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Fosamprenavir 50mg/ml oral suspension 225 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.